Kroopa Joshi

4.8k total citations
23 papers, 552 citations indexed

About

Kroopa Joshi is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Kroopa Joshi has authored 23 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Kroopa Joshi's work include CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (3 papers). Kroopa Joshi is often cited by papers focused on CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (3 papers). Kroopa Joshi collaborates with scholars based in United Kingdom, India and Canada. Kroopa Joshi's co-authors include Sergio A. Quezada, Andrew J.S. Furness, Karl S. Peggs, Juan Martín-Liberal, James Larkin, Benny Chain, Matthew J. Ward, Andrew Feber, Tim R. Fenton and Teresa Marafioti and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Kroopa Joshi

19 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kroopa Joshi United Kingdom 9 304 207 181 111 77 23 552
Miranda P. Dierselhuis Netherlands 13 160 0.5× 131 0.6× 164 0.9× 97 0.9× 33 0.4× 32 540
Junxia Yao China 13 144 0.5× 149 0.7× 216 1.2× 63 0.6× 31 0.4× 46 499
Andrea K. Miyahira United States 14 261 0.9× 177 0.9× 288 1.6× 153 1.4× 231 3.0× 31 690
Melanie Bevier Germany 15 242 0.8× 138 0.7× 100 0.6× 97 0.9× 45 0.6× 19 494
Arnold Baars Netherlands 11 363 1.2× 189 0.9× 356 2.0× 53 0.5× 47 0.6× 23 592
Johann Hermann Germany 6 174 0.6× 225 1.1× 96 0.5× 98 0.9× 25 0.3× 8 578
Ji Cheng United States 3 335 1.1× 263 1.3× 43 0.2× 80 0.7× 51 0.7× 7 534
Jeonghwan Youk South Korea 12 162 0.5× 240 1.2× 34 0.2× 118 1.1× 91 1.2× 40 506
Michelle Tseng Singapore 10 133 0.4× 115 0.6× 177 1.0× 29 0.3× 53 0.7× 21 458
Petra Martin Ireland 12 201 0.7× 140 0.7× 72 0.4× 96 0.9× 161 2.1× 32 448

Countries citing papers authored by Kroopa Joshi

Since Specialization
Citations

This map shows the geographic impact of Kroopa Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kroopa Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kroopa Joshi more than expected).

Fields of papers citing papers by Kroopa Joshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kroopa Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kroopa Joshi. The network helps show where Kroopa Joshi may publish in the future.

Co-authorship network of co-authors of Kroopa Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Kroopa Joshi. A scholar is included among the top collaborators of Kroopa Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kroopa Joshi. Kroopa Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joshi, Kroopa, Antonella Cammarota, Rachel Woodford, et al.. (2025). Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical Trials. JCO Precision Oncology. 9(9). e2400896–e2400896.
2.
3.
4.
5.
Joshi, Kroopa, et al.. (2023). TCR sequencing: applications in immuno-oncology research. Immuno-Oncology Technology. 17. 100373–100373. 9 indexed citations
6.
Joshi, Kroopa, Nadia Yousaf, Sanjay Popat, et al.. (2021). Safety monitoring of two and four-weekly adjuvant durvalumab for patients with stage III NSCLC: implications for the COVID-19 pandemic and beyond. Lung Cancer. 156. 147–150. 5 indexed citations
7.
Joshi, Kroopa, Martina Milighetti, & Benny Chain. (2021). Application of T cell receptor (TCR) repertoire analysis for the advancement of cancer immunotherapy. Current Opinion in Immunology. 74. 1–8. 20 indexed citations
8.
Battisti, Nicolò Matteo Luca, et al.. (2021). Systemic therapy for older patients with early breast cancer. Cancer Treatment Reviews. 100. 102292–102292. 8 indexed citations
9.
10.
Angelis, Vasileios, Zayd Tippu, Kroopa Joshi, et al.. (2020). Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer. European Journal of Cancer. 136. 99–106. 21 indexed citations
11.
Uddin, Imran, Annemarie Woolston, Thomas Peacock, et al.. (2019). Quantitative analysis of the T cell receptor repertoire. Methods in enzymology on CD-ROM/Methods in enzymology. 629. 465–492. 8 indexed citations
12.
Uddin, Imran, Kroopa Joshi, Theres Oakes, et al.. (2018). An Economical, Quantitative, and Robust Protocol for High-Throughput T Cell Receptor Sequencing from Tumor or Blood. Methods in molecular biology. 1884. 15–42. 8 indexed citations
13.
Chakravarthy, Ankur, Andrew J.S. Furness, Kroopa Joshi, et al.. (2018). Pan-cancer deconvolution of tumour composition using DNA methylation. Nature Communications. 9(1). 3220–3220. 195 indexed citations
14.
Joshi, Kroopa, Benny Chain, Karl S. Peggs, & Sergio A. Quezada. (2017). The “Achilles' Heel” of Cancer and Its Implications for the Development of Novel Immunotherapeutic Strategies. Cold Spring Harbor Perspectives in Medicine. 8(1). a027086–a027086. 12 indexed citations
15.
Wong, Yien Ning Sophia, Kroopa Joshi, Martin Pulé, et al.. (2017). Evolving adoptive cellular therapies in urological malignancies. The Lancet Oncology. 18(6). e341–e353. 27 indexed citations
16.
17.
Stares, Mark, Samra Turajlic, Andrew J.S. Furness, et al.. (2016). ADAPTeR: A phase II study of anti-PD1 (nivolumab) therapy as pre- and post-operative therapy in metastatic renal cell carcinoma.. Journal of Clinical Oncology. 34(15_suppl). TPS4583–TPS4583. 5 indexed citations
18.
Martín-Liberal, Juan, Andrew J.S. Furness, Kroopa Joshi, et al.. (2015). Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report. Cancer Immunology Immunotherapy. 64(6). 765–767. 123 indexed citations
19.
Joshi, Kroopa, et al.. (1986). Cellular proliferation in the rat mammary gland during pregnancy and lactation.. PubMed. 54(1). 52–61. 33 indexed citations
20.
Joshi, Kroopa, et al.. (1973). Oral histoplasmosis in India. The Journal of Laryngology & Otology. 87(2). 165–170. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miranda P. Dierselhuis Breakdown of academic impact, for papers by Junxia Yao Breakdown of academic impact, for papers by Andrea K. Miyahira Breakdown of academic impact, for papers by Melanie Bevier Breakdown of academic impact, for papers by Arnold Baars Breakdown of academic impact, for papers by Johann Hermann Breakdown of academic impact, for papers by Ji Cheng Breakdown of academic impact, for papers by Jeonghwan Youk Breakdown of academic impact, for papers by Michelle Tseng Breakdown of academic impact, for papers by Petra Martin
Rankless by CCL
2026